Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVESICALStandard

CYSVIEW KIT

HEXAMINOLEVULINATE HYDROCHLORIDE

Standard Dose
100MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview CYSVIEW KIT is listed in Drugs@FDA under application 022555 (NDA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient HEXAMINOLEVULINATE HYDROCHLORIDE Form and strength FOR SOLUTION;INTRAVESICAL - 100MG/VIAL Sponsor PHOTOCURE ASA Submission history Latest submission status date: 2018-02-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYSVIEW KIT is listed in Drugs@FDA under application 022555 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient HEXAMINOLEVULINATE HYDROCHLORIDE Form and strength FOR SOLUTION;INTRAVESICAL - 100MG/VIAL Sponsor PHOTOCURE ASA Submission history Latest submission status date: 2018-02-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.